Level has designed Noctrix Nidra, a pioneering prescription-grade, non-pharmaceutical wearable solution for the management of Restless Legs Syndrome (RLS).

Nidra is the first drug-free wearable therapy clinically proven to relieve Restless Legs Syndrome (RLS), a neurological sleep disorder that causes intense discomfort and an uncontrollable urge to move the legs.

Using neurostimulation, Nidra targets leg nerves to alleviate symptoms. It received FDA 'Breakthrough Device Designation' and is backed by 10,000+ nights of clinical data and six peer-reviewed studies, with 91 per cent of users reporting relief.

Recommended by the American Academy of Sleep Medicine, Nidra is now covered by Medicare and Medicaid, expanding access to its high-frequency bilateral peroneal nerve stimulation therapy.

This project has been longlisted in the product design (health, wellbeing and wearables) category of Dezeen Awards 2025.

Studio: Level
Project: Noctrix Nidra